The 1st International Society of Hematology Webinar has ended in a great success.
Thank you for your attendance and cooperation.
|Date||July 16 (Sunday), 2023|
|President||Kinuko Mitani, MD, PhD
(Department of Hematology and Oncology, Dokkyo Medical University, Japan)
International Society of Hematology, Asian-Pacific Division
Secretary-General：Takahiro Suzuki, MD, PhD
The 1st International Society of Hematology Webinar
Chair of Council in ISH
Department of Hematology and Oncology,
Dokkyo Medical University, Japan
My name is Kinuko Mitani and am taking a role of chair of council in International Society of Hematology (ISH). It is my great honor to run the 1st Webinar of ISH as the president that will be delivered from Japan to the world.
ISH was founded in 1946 and is the oldest international hematology society concerned with advancing scientific research as well as the practice of hematology at both clinical and laboratory levels. ISH membership is open to any person with medical or scientific qualification of good professional standing in hematology. ISH has over 4,500 active members worldwide.
ISH has three divisions: Asian and Pacific Division (APD), European and African Division (EAD), Inter-American Division (IAD) and organizes the congress every other year with a rotation of the venue among APD, EAD and IAD. Last year, we had the ISH2022 congress in Barcelona, Spain, and will conduct the ISH2024 congress in Bangkok, Thailand. However, under a circumstance of the pandemic of COVID19 during these three years, our activities have been restricted so much. This time, we have planed the 1st Webinar to enhance our activities and make all the hematologists in the world get together.
Main topic of the 1st Webinar is “bone marrow failure syndrome”. We have scheduled three symposia (ASH-ISH joint, EHA-ISH joint, and Asian Symposium) and three sponsored seminars for aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes. Although registration is required, we will not collect registration fee and welcome all the hematologists in the world.
Considering the time difference, major part of participants may come from the AP division. However, we hope that this Webinar will provide a great opportunity for exchange of hematologists all over the world.
February 4, 2023
ASH-ISH Joint Session：Congenital Bone Marrow Failure Syndromes
9:00-10:30 (JST) 0:00-1:30 (UTC)
|Chair：||Miguel HerreraCV（Bone Marrow Transplant Program at Hospital Lomas de San Luis, Mexico）|
|Decoding Inherited Bone Marrow Failure Syndromes: Bridging the Gap between Genetic Analysis and Clinical Diagnosis|
（Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan）
|Congenital Neutropenia Syndromes – from Pathogenesis to Leukemic Transformation|
|Speaker：||Julia T. WarrenCVAbstracts
（University of Pennsylvania, Children’s Hospital of Philadelphia, USA）
|Comprehensive Genomics in Bone Marrow Failure: from Diagnosis to Therapy Stratification|
（Department of Hematology, St. Jude Children’s Research Hospital, Memphis, USA）
Sponsored Session: AA Sponsored by Novartis Pharma K.K.
10:45-11:15 (JST) 1:45-2:15 (UTC)
Sponsored Session: PNH Sponsored by Alexion Pharma GK
11:30-12:00 (JST) 2:30-3:00 (UTC)
Asian Session：Therapy for AA in Asia
13:00-14:30 (JST) 4:00-5:30 (UTC)
（Department of Hematology, Kitasato University School of Medicine, Japan）
|Immunosuppressive therapy and anabolic hormone treatment for aplastic anemia; A lesson learned from Thailand|
（Division of Hematology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand）
|Unmet needs in Severe Aplastic anemia|
（Department of Haematology, Tan Tock Seng Hospital, Singapore）
|Management of severe aplastic anemia in Taiwan, from the perspective of real-world evidence|
|Speaker：||Yu-Chin HungCVAbstracts （Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Hu-Wei Region, Taiwan）|
|Management of Aplastic Anemia in East Malaysia|
|Speaker：||Lily Wong Lee LeeCVAbstracts （Department of Hematology, Hospital Queen Elizabeth, Malaysia）|
|Current treatment of aplastic anemia patients in Japan|
（Department of Hematology, University of Tsukuba, Japan）
Sponsored Session: MDS Sponsored by AbbVie GK
14:45-15:15 (JST) 5:45-6:15 (UTC)
（Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Japan）
|Predisposition to Myeloid Neoplasms caused by Germline DDX41 Variants|
（Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan）
EHA-ISH Joint Session：Recent Progresses in the Therapy of MDS
15:30-17:00 (JST) 6:30-8:00 (UTC)
（Pediatrics and Pediatric Hematology, Yeditepe University Faculty of Medicine, Istanbul, Turkey）
|Novel Approaches in Lower-risk MDS|
|Speaker：||Uwe PlatzbeckerCVAbstracts （Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Germany）|
|Recent Progress in the Treatment of Lower Risk MDS|
（Département (DMU) d’hématologie et immunologie, APHP Nord, Service d'hématologie séniors, Hôpital St Louis, université de Paris, France）
|Clinical Trials for HR-MDS in Japan Adult Leukemia Study Group|
|Speaker：||Yasushi MiyazakiCVAbstracts （Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Japan）|
© 2023 The 1st International Society of Hematology Webinar